CFO and Chief Corp. Dev. Off · Humacyte, Inc. · Common Stock
Side
SELL
Value
$41K
Shares
45.9K
Price
$0.9
Executed
May 18, 2026
Disclosed
May 20, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
May 18 executedMay 20, 2026 disclosed
HUMA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Sander Dale A. filed this Form 4 reporting a open-market sale of HUMA on May 18, 2026. It became public on May 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CFO and Chief Corp. Dev. Off
Sander Dale A.cik:0001878193
Issuer
Humacyte, Inc.cik:0001818382
Revision history · 0
No field has changed since this record was first ingested.
